These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 15977465

  • 1. Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Aging Clin Exp Res; 2005 Apr; 17(2):157-63. PubMed ID: 15977465
    [Abstract] [Full Text] [Related]

  • 2. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Yonsei Med J; 2004 Aug 31; 45(4):676-82. PubMed ID: 15344210
    [Abstract] [Full Text] [Related]

  • 3. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    J Bone Miner Metab; 2005 Aug 31; 23(3):238-42. PubMed ID: 15838627
    [Abstract] [Full Text] [Related]

  • 4. Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Clin Rheumatol; 2004 Oct 31; 23(5):383-9. PubMed ID: 15278749
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Yonsei Med J; 2005 Dec 31; 46(6):750-8. PubMed ID: 16385649
    [Abstract] [Full Text] [Related]

  • 6. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.
    Menopause; 2013 Jan 31; 20(1):72-8. PubMed ID: 22968256
    [Abstract] [Full Text] [Related]

  • 7. Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Ichimura S, Uzawa M.
    Keio J Med; 2003 Jun 31; 52(2):113-9. PubMed ID: 12862363
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Clin Rheumatol; 2007 Feb 31; 26(2):161-7. PubMed ID: 16565894
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis.
    Deng J, Feng Z, Li Y, Pan T, Li Q, Zhao C.
    Medicine (Baltimore); 2018 Nov 31; 97(47):e13341. PubMed ID: 30461654
    [Abstract] [Full Text] [Related]

  • 10. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
    Johnell O, Scheele WH, Lu Y, Reginster JY, Need AG, Seeman E.
    J Clin Endocrinol Metab; 2002 Mar 31; 87(3):985-92. PubMed ID: 11889149
    [Abstract] [Full Text] [Related]

  • 11. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M.
    J Orthop Sci; 2003 Mar 31; 8(4):532-7. PubMed ID: 12898306
    [Abstract] [Full Text] [Related]

  • 12. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
    Yamazaki S, Ichimura S, Iwamoto J, Takeda T, Toyama Y.
    J Bone Miner Metab; 2004 Mar 31; 22(5):500-8. PubMed ID: 15316873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis.
    Iwamoto J, Makita K, Sato Y, Takeda T, Matsumoto H.
    Osteoporos Int; 2011 Oct 31; 22(10):2735-42. PubMed ID: 21104227
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group.
    J Clin Endocrinol Metab; 2001 Mar 31; 86(3):1116-25. PubMed ID: 11238495
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
    Ettinger B, San Martin J, Crans G, Pavo I.
    J Bone Miner Res; 2004 May 31; 19(5):745-51. PubMed ID: 15068497
    [Abstract] [Full Text] [Related]

  • 18. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J.
    Bone; 2007 Jul 31; 41(1):122-8. PubMed ID: 17468062
    [Abstract] [Full Text] [Related]

  • 19. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.
    Ruan XY, Jin FY, Liu YL, Peng ZL, Sun YG.
    Chin Med J (Engl); 2008 Jul 05; 121(13):1155-8. PubMed ID: 18710630
    [Abstract] [Full Text] [Related]

  • 20. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.
    Osteoporos Int; 2006 Jul 05; 17(5):716-23. PubMed ID: 16463007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.